XML 17 R6.htm IDEA: XBRL DOCUMENT v3.20.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Operating activities:    
Net loss $ (13,184) $ (27,514)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 3,384 3,106
Non-cash operating lease expense 1,369 1,427
Amortization expense of finance leases 390 574
Amortization of intangible assets 6,918 8,105
Stock-based compensation 2,658 6,953
Deferred tax provision 42 441
Change in fair value of financing derivatives (2,387) (4,100)
Change in fair value of warrants liability (4,651) 0
Change in fair value of investment in equity securities 0 1,712
Impairment of right-of-use and long-lived assets 4,671 0
Accretion of debt discount 1,769 1,319
Amortization of deferred financing costs 348 252
Other 492 (138)
Changes in operating assets and liabilities:    
Accounts receivable 2,820 12,506
Prepaid expenses and other assets (1,022) 1,818
Accounts payable, accrued expenses and other liabilities (9,522) (2,544)
Contract liability and customer advances 2,893 (2,500)
Operating lease liabilities (1,769) (2,993)
Net cash used in operating activities (4,781) (1,576)
Investing activities:    
Proceeds from sale of investment in equity securities 0 705
Purchases of property and equipment (45) (1,836)
Capitalized internal-use software costs (3,872) (3,109)
Net cash used in investing activities (3,917) (4,240)
Financing activities:    
Proceeds from the exercise of stock options 0 1,191
Payments for taxes related to net share settlement of equity awards (65) (1,138)
Principal payments on finance leases (407) (694)
Principal payments on software license arrangements (77) (823)
Net cash used in financing activities (549) (1,464)
Effect of exchange rate changes on cash, cash equivalents and restricted cash (927) (75)
Net decrease in cash, cash equivalents and restricted cash (10,174) (7,355)
Cash, cash equivalents and restricted cash at beginning of period 66,773 50,198
Cash, cash equivalents and restricted cash at end of period 56,599 42,843
Total cash, cash equivalents and restricted cash 56,599 42,843
Supplemental cash flow disclosures:    
Interest paid ($6,120 and $3,046 attributable to related party, respectively) 6,795 3,181
Income taxes paid (received), net of refunds 338 (348)
Supplemental disclosures of non-cash activities:    
Change in accounts payable and accrued expenses related to capital expenditures 423 1,170
Settlement of restricted stock unit liability $ 0 $ 4,610